retatrutide triple agonist gip glp-1 glucagon Is better than tirzepatide? vs dual compared Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

He has been featured in major media publications and shows over 2,500 times throughout his career

In addition, 70% of those that are living with obesity are in middle- and low-income countries, which could pose barriers in accessing GLP-1 drugs that are expensive and may not be affordable

"Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials." Diabetes, Obesity and Metabolism , 2026;28(1):83-93

Comorbidities were similar between patients on GLP-1 analog monotherapy and combination therapy

Amliore l'apparence de la silhouette et des zones localises

The gut and beyond: GI effects and other tissues Why does receptor biology matter for drug discovery